NCRA vs RARE · rev $4.4M vs rev $350.0M
Nocera Inc (NCRA) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Nocera Inc (NCRA) is a packaged foods company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported NCRA revenue for 2026-06-30 was $4.4M. Net income was -$2.8M. Revenue was up 93.9% from 2026-03-31 to 2026-06-30. NCRA currently screens at market cap $4.0M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
NCRA currently screens at market cap $4.0M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the NCRA and RARE stock pages for the full models.
Not investment advice.